Reata's Bardoxolone Promises Renal Benefits In Alport Syndrome

Another Positive Read-Out For A Clinical-Stage Reata Drug

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.